Are you Dr. Van Ummersen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 56 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Florida Cancer Specialists (ORC)
765 Image Way
Orange City, FL 32763Phone+1 386-774-7411Fax+1 386-774-7412- Is this information wrong?
Summary
- Dr. Lynn Van Ummersen, MD is an oncologist in Orange City, Florida. She is currently licensed to practice medicine in Florida, Wisconsin, and Illinois. She is affiliated with AdventHealth Fish Memorial and Central Florida Regional Hospital.
Education & Training
- Georgetown University HospitalFellowship, Medical Oncology, 1995 - 1997
- University of MarylandResidency, Internal Medicine, 1992 - 1994
- UMass Chan Medical SchoolInternship, Internal Medicine, 1991 - 1992
- University of Massachusetts Medical SchoolClass of 1991
Certifications & Licensure
- FL State Medical License 2007 - 2025
- WI State Medical License 1998 - 2007
- IL State Medical License 1998 - 2002
- DC State Medical License 1996 - 1998
- MD State Medical License 1994 - 1995
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Publications & Presentations
PubMed
- 8 citationsCapecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trialUchenna O. Njiaju, Amye J. Tevaarwerk, KyungMann Kim, J. E. Chang, R. M. Hansen, T. L. Champeny, Anne M. Traynor, S. Meadows, L. Van Ummersen, K. Powers, James A. Stewart> ;Cancer Chemotherapy and Pharmacology. 2013 Mar 1
- A dose escalation trial of fixed dose gemcitabine and capecitabine.Morgan Meadows S, Van Ummersen L, Brandon H, Oliver K, Houston M, Eickhoff J, Wilding G> ;J. Clin. Oncol.. 2006-06-20
- 177 citationsA phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metas...Eric J. Small, Michael A. Carducci, James M. Burke, Ronald Rodriguez, Lawrence Fong, Lynn Van Ummersen, De-Chao Yu, Junko Aimi, Dale Ando, David H. Kirn, George Wilding> ;Molecular Therapy. 2006 Jul 1
- Join now to see all
Hospital Affiliations
- Central Florida Regional HospitalSanford, Florida
- AdventHealth Fish MemorialOrange City, Florida